3Cohen G,H(o)rl WH. Resistin as a cardiovascular and atherosclerotic risk factor and uremic toxin[J].Seminars in Dialysis,2009,(04):373-377.doi:10.1111/j.1525-139X.2009.00583.x.
4Cheung AK,Sarnak MJ,Yan G. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients[J].Kidney International,2000,(01):353-362.doi:10.1046/j.1523-1755.2000.00173.x.
5Reilly MP,Lehrke M,Wolfe ML. Resistin is an inflammatory marker of atherosclerosis in humans[J].Circulation,2005,(07):932-939.
6Karbowska A,Boratynska M,Kusztal M. Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients[J].Transplantation Proceedings,2009,(08):3052-3055.doi:10.1016/j.transproceed.2009.07.080.
7Boratynska M,Karbowska A,Klinger M. The effect of hyperuricemia on endothelial biomarkers and renal function in kidney allograft recipients[J].Transplantation Proceedings,2010,(10):4074-4077.doi:10.1016/j.transproceed.2010.09.069.
8Filippidis G,Liakopoulos V,Mertens PR. Resistin serum levels are increased but not correlated with insulin resistance in chronic hemodialysis patients[J].Blood Purification,2005,(06):421-428.doi:10.1159/000088017.
9Malyszko J,Malyszko JS,Kozminski P. Elevated resistin is related to inflammation and residual renal function in haemodialysed patients[J].Nephrology,2007,(03):246-253.
10Schomig M,Eisenhandt A,Ritz E. The microinflammatory state of uremia[J].Blood Pur If,2000,(4):327-332.doi:10.1159/000014457.
